The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
Sign in to access this content
Sign InAmid a broader trend of upward revisions in the insurance sector this July, TD Cowen has significantly raised its price target for MetLife (MET). According to reports, the firm increased its target to $105 from the previous $87 while reiterating a Buy rating. This adjustment reflects growing analyst confidence in the company's valuation and its potential for continued performance growth.
The upward revision follows a series of similar target adjustments throughout July, indicating sustained market momentum for the insurer. Per market data, MET shares closed at $93.37 on July 21, 2026, having traded between a day high of $93.47 and a low of $92.16. The new target suggests significant perceived upside from these recent trading levels.
Investors should watch for the stock's ability to maintain levels above the $92.16 support (July 21 low) as it tracks toward the $105 objective. While the upcoming economic calendar shows no direct catalysts for MetLife, broader financial sector sentiment remains sensitive to macroeconomic data and Federal Reserve communications regarding the interest rate environment.